Evidence map›Paper›PMID 40539354›Full record

ReviewRecent patents on biotechnology2026

Cognition, Diagnosis, and Treatment of Alzheimer's Disease: A Review.

Yuping Qin, Xiangxia Deng, Shuang Zhang

Abstract readReview
PubMed Publisher
In one paragraph

Review in Recent patents on biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yuping QinThe School of Artificial Intelligence, Neijiang Normal University, Neijiang, 641000, China.
Xiangxia DengPeople's Hospital of Dongxing District, Neijiang, 641000, China.
Shuang ZhangThe School of Artificial Intelligence, Neijiang Normal University, Neijiang, 641000, China.

Funding

China Postdoctoral Science Foundation 2020M683294Foundation of Ph.D. Scientific Research of Neijiang Normal University 18B19National Key Research and Development Program of China 2016YFC0100800, 2016YFC0100802Science and Technology Innovation 2030-Brain Science and Brain-inspired Artificial Intelligence Key Project 2022ZD0208506Sichuan Applied Psychology Research Center of Chengdu Medical College CSXL-23305Sichuan Science and Technology Program 2025ZNSFSC0780, 2022JDRC0134, 2022YFH0110, 2021YFSC0040
6 · The paper itself

Abstract

As the global population ages, the health of older adults has become a growing concern. Alzheimer's disease (AD) is a common ailment affecting older adults, but the diagnosis and treatment of AD are difficult given our insufficient understanding of the disease. This review article and patents aim to provide reliable information for patients and their families by presenting a detailed overview of the pathogenic factors, diagnostic methods, and clinical manifestation of AD, as well as advances in drug and physical therapies. The information presented here should help provide a more comprehensive understanding of AD for patients and their families and encourage family- or self-screening based on clinical manifestations, thus improving early AD detection. In addition, the current treatment methods for AD are summarized. Although a goldstandard treatment for AD is yet to be developed, controlled-release therapies and medications that slow disease progression or improve cognitive function are available. The appropriate treatment method depends on the patient's diagnosis and the local medical level, and the effectiveness of the treatments may vary. Therefore, improving our understanding of AD and cognition-related symptoms in the public is necessary to improve early AD diagnoses. This review provides information that will facilitate self-screening for AD based on clinical manifestations, which can improve the early clinical diagnosis rate.

Indexed as

Alzheimer DiseaseCognitionEarly DiagnosisHumansPatents as TopicAlzheimer’s diseasediagnosisrecognitionrepetitive transcranial magnetic stimulationtEStreatment

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.